CG Invites Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 87

Employees

  • Stock Symbol
  • 083790

Stock Symbol

  • Investments
  • 12

  • Share Price
  • $0.57
  • (As of Friday Closing)

CG Invites General Information

Description

CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

Contact Information

Formerly Known As
Crystal Genomics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 38 Magokjungang 8
  • Seoul, Gangseo
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 38 Magokjungang 8
  • Seoul, Gangseo
  • South Korea
+82

CG Invites Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CG Invites Stock Performance

As of 13-Nov-2026, CG Invites’s stock price is $0.57. Its current market cap is $43.4M with 76.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.57 $0.57 $0.49 - $1.16 $43.4M 76.9M 167K

CG Invites Financials Summary

As of 30-Jun-2026, CG Invites has a trailing 12-month revenue of $20.7M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 76,468 110,318 125,488 151,523
Revenue 20,747 19,247 5,316 3,731
EBITDA (5,660) (7,379) (31,902) (36,926)
Net Income 296 (2,474) (37,777) (37,419)
Total Assets 142,613 155,630 176,830 188,655
Total Debt 29,448 32,264 36,292 24,834
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CG Invites Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CG Invites‘s full profile, request access.

Request a free trial

CG Invites Patents

CG Invites Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026112320-A1 Use of multidose of ivaltinostat for treating cancer Pending 22-Nov-2024
WO-2026038703-A1 Biological age estimation device and method based on disease risk Pending 12-Aug-2024
WO-2026038702-A1 Comprehensive disease risk prediction device and method Pending 12-Aug-2024
WO-2026038704-A1 Comprehensive disease risk prediction device and method considering associated disease risk Pending 12-Aug-2024
WO-2026038935-A1 Periodic variable disease risk prediction device and method Pending 12-Aug-2024
To view CG Invites’s complete patent history, request access »

CG Invites Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CG Invites Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CG Invites‘s full profile, request access.

Request a free trial

CG Invites Investments & Acquisitions (12)

CG Invites’s most recent deal was a Joint Venture with VIDW. The deal was made on 17-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
VIDW 17-Sep-2026 Joint Venture Enterprise Systems (Healthcare)
Guam Regional Medical City 02-Jul-2024 Merger/Acquisition Clinics/Outpatient Services
Machaon Biotherapeutics 15-Apr-2024 Merger/Acquisition Biotechnology
PanGen Biotech 27-Mar-2024 PIPE Pharmaceuticals
PanGen Biotech 22-Nov-2022 PIPE Pharmaceuticals
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

CG Invites ESG

Risk Overview

Risk Rating

Updated August, 31, 2022

32.95 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Pharmaceuticals

Industry

of 891

Rank

Percentile

Biotechnology

Subindustry

of 394

Rank

Percentile

To view CG Invites’s complete esg history, request access »

CG Invites Exits (3)

CG Invites’s most recent exit was on 07-Dec-2015 from HuonsLifeSciences. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
HuonsLifeSciences 07-Dec-2015 Completed
  • 2 buyers
Palkion 17-Aug-2009 Completed
  • 2 buyers
Palkion 01-Mar-2008 Early Stage VC Completed
  • 2 buyers
To view CG Invites’s complete exits history, request access »

CG Invites Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Invites Ventures Seoul, South Korea 2019
Guam Regional Medical City Dededo, GU 2015
BexPharm Healthcare Seoul, South Korea 1998
Hwail Pharmaceutical Pyeongtaek, South Korea 1974

CG Invites FAQs

  • When was CG Invites founded?

    CG Invites was founded in 2000.

  • Where is CG Invites headquartered?

    CG Invites is headquartered in Seoul, South Korea.

  • What is the size of CG Invites?

    CG Invites has 87 total employees.

  • What industry is CG Invites in?

    CG Invites’s primary industry is Drug Discovery.

  • Is CG Invites a private or public company?

    CG Invites is a Public company.

  • What is CG Invites’s stock symbol?

    The ticker symbol for CG Invites is 083790.

  • What is the current stock price of CG Invites?

    As of 13-Nov-2026 the stock price of CG Invites is $0.57.

  • What is the current market cap of CG Invites?

    The current market capitalization of CG Invites is $43.4M.

  • What is CG Invites’s current revenue?

    The trailing twelve month revenue for CG Invites is $20.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process